| Title : Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study - Ren_2025_Front.Immunol_16_1692632 |
| Author(s) : Ren L , Chen D , Zhang X , She S , Fei R , Cong X , Mu S , Zhou Y , Gao J , Liao W , Chen H |
| Ref : Front Immunol , 16 :1692632 , 2025 |
| Abstract : |
| PubMedSearch : Ren_2025_Front.Immunol_16_1692632 |
| PubMedID: 41376633 |
| Title : Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study - Ren_2025_Front.Immunol_16_1692632 |
| Author(s) : Ren L , Chen D , Zhang X , She S , Fei R , Cong X , Mu S , Zhou Y , Gao J , Liao W , Chen H |
| Ref : Front Immunol , 16 :1692632 , 2025 |
| Abstract : |
| PubMedSearch : Ren_2025_Front.Immunol_16_1692632 |
| PubMedID: 41376633 |
| Title : Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study - Ren_2025_Front.Immunol_16_1692632 |
| Author(s) : Ren L , Chen D , Zhang X , She S , Fei R , Cong X , Mu S , Zhou Y , Gao J , Liao W , Chen H |
| Ref : Front Immunol , 16 :1692632 , 2025 |
| Abstract : |
| PubMedSearch : Ren_2025_Front.Immunol_16_1692632 |
| PubMedID: 41376633 |
| Title : Soluble epoxide hydrolase inhibitor, t-AUCB, improves salivary gland function by ameliorating endothelial injury - Han_2022_Life.Sci_308_120942 |
| Author(s) : Han WW , Wang XR , He YF , Zhang HS , Cong X , Xiang RL , Wu LL , Yu GY , Liu LM , Zhang Y |
| Ref : Life Sciences , 308 :120942 , 2022 |
| Abstract : |
| PubMedSearch : Han_2022_Life.Sci_308_120942 |
| PubMedID: 36096247 |
| Title : Soluble epoxide hydrolase inhibitor, t-AUCB, improves salivary gland function by ameliorating endothelial injury - Han_2022_Life.Sci_308_120942 |
| Author(s) : Han WW , Wang XR , He YF , Zhang HS , Cong X , Xiang RL , Wu LL , Yu GY , Liu LM , Zhang Y |
| Ref : Life Sciences , 308 :120942 , 2022 |
| Abstract : |
| PubMedSearch : Han_2022_Life.Sci_308_120942 |
| PubMedID: 36096247 |
| Title : Soluble epoxide hydrolase inhibitor, t-AUCB, improves salivary gland function by ameliorating endothelial injury - Han_2022_Life.Sci_308_120942 |
| Author(s) : Han WW , Wang XR , He YF , Zhang HS , Cong X , Xiang RL , Wu LL , Yu GY , Liu LM , Zhang Y |
| Ref : Life Sciences , 308 :120942 , 2022 |
| Abstract : |
| PubMedSearch : Han_2022_Life.Sci_308_120942 |
| PubMedID: 36096247 |